Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Farinati

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Gastroenterology|July 1, 1996
Tamoxifen treatment in hepatocellular carcinomaF Farinati
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 27, 2001
Surveillance for hepatocellular carcinoma in cirrhosis: is it cost-effective?F Farinati, S Gianni
Digestive Diseases and Sciences|August 1, 1991
Hepatocellular carcinoma, alcohol, and cirrhosis: facts and hypothesesR Naccarato, F Farinati
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 6, 2001
Gastroenterological oncology: a top priorityM Crespi, F Farinati
European Journal of Clinical Nutrition|June 20, 2013
Coffee, chronic diseases and cancerF Farinati, R Cardin, M Piciocchi
Alimentary Pharmacology & Therapeutics|March 5, 2014
Letter: coffee and chronic liver damageR Cardin, M Piciocchi, F Farinati
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1985
The risk of gastric dysplasia in medical long-term treatment of peptic ulcer diseaseF Di Mario, F Farinati, F Cardin
Cancer|January 9, 2001
How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic systemF Farinati, M Rinaldi, S Gianni, et al.
Hepatology (Baltimore, Md.)|October 31, 1998
Transcatheter arterial chemoembolization in hepatocellular carcinomaF Farinati, M Rinaldi, S Gianni, et al.
Journal of Hepatology|July 1, 1996
Cysteine and glutathione in the liver of patients with primary biliary cirrhosisF Farinati, R Cardin, R Naccarato, et al.
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Gastroenterology|July 1, 1996
Tamoxifen treatment in hepatocellular carcinomaF Farinati
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 27, 2001
Surveillance for hepatocellular carcinoma in cirrhosis: is it cost-effective?F Farinati, S Gianni
Digestive Diseases and Sciences|August 1, 1991
Hepatocellular carcinoma, alcohol, and cirrhosis: facts and hypothesesR Naccarato, F Farinati
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 6, 2001
Gastroenterological oncology: a top priorityM Crespi, F Farinati
European Journal of Clinical Nutrition|June 20, 2013
Coffee, chronic diseases and cancerF Farinati, R Cardin, M Piciocchi
Alimentary Pharmacology & Therapeutics|March 5, 2014
Letter: coffee and chronic liver damageR Cardin, M Piciocchi, F Farinati
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1985
The risk of gastric dysplasia in medical long-term treatment of peptic ulcer diseaseF Di Mario, F Farinati, F Cardin
Cancer|January 9, 2001
How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic systemF Farinati, M Rinaldi, S Gianni, et al.
Hepatology (Baltimore, Md.)|October 31, 1998
Transcatheter arterial chemoembolization in hepatocellular carcinomaF Farinati, M Rinaldi, S Gianni, et al.
Journal of Hepatology|July 1, 1996
Cysteine and glutathione in the liver of patients with primary biliary cirrhosisF Farinati, R Cardin, R Naccarato, et al.
Pageof 15